UiPath (NYSE:PATH) Trading 0.5% Higher

Shares of UiPath Inc. (NYSE:PATH - Get Free Report) rose 0.5% during mid-day trading on Friday . The company traded as high as $19.75 and last traded at $19.50. Approximately 1,296,716 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 8,657,022 shares. The stock had previously closed at $19.41.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Barclays lifted their price objective on UiPath from $23.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Friday, March 15th. Evercore ISI upped their price objective on shares of UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a report on Thursday, March 14th. Morgan Stanley lifted their target price on shares of UiPath from $17.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Thursday, March 14th. Canaccord Genuity Group increased their price target on shares of UiPath from $27.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, March 15th. Finally, Mizuho lifted their price target on shares of UiPath from $22.00 to $25.00 and gave the company a "neutral" rating in a research report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, UiPath currently has a consensus rating of "Moderate Buy" and an average target price of $27.41.

UiPath Stock Up 0.3 %

The firm has a market cap of $11.07 billion, a price-to-earnings ratio of -114.70 and a beta of 0.96. The company's 50-day moving average price is $22.30 and its 200-day moving average price is $21.53.

UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The company had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. On average, sell-side analysts predict that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Activity at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of UiPath stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the sale, the chief financial officer now directly owns 87,505 shares of the company's stock, valued at approximately $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last three months, insiders sold 72,000 shares of company stock worth $1,591,360. Company insiders own 31.03% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath in the 4th quarter valued at $25,000. HighMark Wealth Management LLC acquired a new position in UiPath during the fourth quarter worth approximately $27,000. Cypress Capital Management LLC WY purchased a new stake in UiPath in the fourth quarter valued at approximately $29,000. Fifth Third Bancorp boosted its holdings in shares of UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock valued at $34,000 after acquiring an additional 1,905 shares during the period. Finally, GAMMA Investing LLC purchased a new position in shares of UiPath during the fourth quarter worth approximately $36,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.